We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ALE:GPWAllegro.eu S.A. Analysis

Data as of 2026-06-12 - not real-time

$52.77

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Alexandria Real Estate Equities has demonstrated a notable earnings turnaround, posting a positive net income and EPS after a prior loss, which bolsters confidence in its operational resilience. Technical analysis shows the short‑term moving average sitting above the medium‑term average while remaining below the long‑term average, indicating a mixed momentum profile. The RSI is comfortably above the midpoint, suggesting lingering buying pressure, and the MACD line is above its signal, reinforcing a bullish bias. Volume is on an upward trend, supporting the price action, yet the overall trend direction is flagged as neutral and volatility is elevated, highlighting potential price swings. The stock trades at a price‑to‑book well below one, and the dividend yield is among the higher tiers for the sector, but a discounted cash flow estimate sits substantially below the current market price, pointing to possible overvaluation. Fundamentally, the company carries a high debt load relative to equity and shows negative profitability margins, though cash flow generation remains solid. The combination of strong dividend support, high beta, and sector‑specific risks creates a nuanced outlook. Investors should weigh the earnings recovery against valuation concerns and the elevated volatility when forming a view.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Bullish MACD crossover
  • Increasing trading volume
  • Price below long‑term moving average

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Sustained dividend yield
  • Overvaluation relative to DCF
  • Neutral trend with elevated volatility

Long Term

> 3 years
Cautious
Model confidence: 5/10

Key Factors

  • High debt‑to‑equity ratio
  • Negative profit margins
  • Price significantly above intrinsic value estimate

Key Metrics & Analysis

Financial Health

Revenue Growth-11.50%
Profit Margin-36.14%
P/E Ratio-60.0
ROE-4.14%
ROA1.00%
Debt/Equity66.51
P/B Ratio0.6
Op. Cash Flow$1.4B
Free Cash Flow$1.4B
Industry P/E33.1

Technical Analysis

TrendNeutral
RSI60.7
Support$44.81
Resistance$55.14
MA 20$49.56
MA 50$46.76
MA 200$57.14
MACDBullish
VolumeIncreasing
Fear & Greed Index86.71

Valuation

Fair Value$33.99
Target Price$51.36
Upside/Downside-2.68%
GradeOvervalued
TypeValue
Dividend Yield5.46%

Risk Assessment

Beta0.98
Volatility46.39%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.